Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
January 28, 2021	3	Initial filing by director officer or owner of more than ten percent.	0001562180-21-000573.pdf 0001562180-21-000573.rtf 0001562180-21-000573.xls View HTML
February 18, 2021	3	Initial filing by director officer or owner of more than ten percent.	0001562180-21-001242.pdf 0001562180-21-001242.rtf 0001562180-21-001242.xls View HTML
November 3, 2021	3	Initial filing by director officer or owner of more than ten percent.	0001562180-21-006800.pdf 0001562180-21-006800.rtf 0001562180-21-006800.xls View HTML
July 18, 2023	3	Initial filing by director officer or owner of more than ten percent.	0001562180-23-005953.pdf 0001562180-23-005953.rtf 0001562180-23-005953.xls View HTML
January 18, 2024	3	Initial filing by director officer or owner of more than ten percent	0001562180-24-000527.pdf 0001562180-24-000527.rtf 0001562180-24-000527.xls View HTML
January 18, 2024	3	Initial filing by director officer or owner of more than ten percent	0001562180-24-000541.pdf 0001562180-24-000541.rtf 0001562180-24-000541.xls View HTML
March 17, 2014	FWP	FWP	0001193125-14-101011.pdf 0001193125-14-101011.rtf View HTML
January 7, 2016	FWP	FWP	0001193125-16-422675.pdf 0001193125-16-422675.rtf 0001193125-16-422675.xls View HTML
October 30, 2018	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	0001193125-18-312414.pdf 0001193125-18-312414.rtf 0001193125-18-312414.xls View HTML
April 14, 2015	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	0001193125-15-129335.pdf 0001193125-15-129335.rtf 0001193125-15-129335.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax